Best Performing Pharma Stocks 2024 USA: FKnol.com

Medicines, drugs and medical devices have been the basic need of human population. The pharma industry aims to serve this fundamental need, by the discovery, production and marketing of the drugs that are aimed to prevent the diseases or offer treatment of the diseases to the mankind. Large and small pharma companies are running across the globe to produce drugs and other related pharma products, and lots of them have their stocks listed on the stock exchanges worldwide.
This allows for a good opportunity to common investors and traders to benefit from the pharma business. However, one must note that the pharma industry is heavily regulated, and approval or rejection of drugs, patent validity, factory conditions, competitor developments, and similar related parameters decide the fortune of the pharma companies.
Among the several pharma companies whose stocks are actively trading on the stock exchanges, which have been the winners in terms of highest returns?
This article provides a list of pharma stocks which have generated the highest returns in the year 2024 till date of writing. The list is prepared based on the percentage returns generated by the individual pharma stocks between the end of the previous and Apr 15, 2024, and the top 10 return generating pharma stocks are listed below.

Best Performing Stock Screener:

This page is updated every week/month. Bookmark this site to track the best performing stocks regularly.
Top Performing Pharma StocksAll Pharma StocksAll Pharma ETFsTop Dividend-paying Pharma StocksTop Pharma Stocks for Apr 2024

Top Pharma Stocks With Highest Returns

The following list presents stocks of the companies which belong to the broader Pharma sector or the stock market index, their corresponding prices as of given date, and the percentage gains realized:

1) Shineco, Inc. (SISI)

Price Gain: 486.15% 2024 year-to-date
Current Price: $0.66
Market Capitalization: $4.23 million
52-week Price Range: $0.61 - $7.5
No ETFs - No Recent Candlestick Patterns

2) ZVZZT Pharma Corp Ltd. (ZVZZT)

Price Gain: 187.88% 2024 year-to-date
Current Price: $21.43
Market Capitalization: $1111.11 billion
52-week Price Range: $0.42 - $18.12
Members Only! Login / Register to view

3) Nektar Therapeutics (NKTR)

Price Gain: 177.88% 2024 year-to-date
Current Price: $1.57
Market Capitalization: $306.64 million
52-week Price Range: $0.41 - $1.75
ETFs holding NKTR - No Recent Candlestick Patterns

4) ZVZZT Pharma Corp Ltd. (ZVZZT)

Price Gain: 139.63% 2024 year-to-date
Current Price: $21.43
Market Capitalization: $1111.11 billion
52-week Price Range: $9.96 - $100.82
Members Only! Login / Register to view

5) Clever Leaves Holdings Inc. (CLVRW)

Price Gain: 135.80% 2024 year-to-date
Current Price: $0.04
Market Capitalization: $0 million
52-week Price Range: $0.01 - $0.05
No ETFs - No Recent Candlestick Patterns

6) ZVZZT Pharma Corp Ltd. (ZVZZT)

Price Gain: 121.29% 2024 year-to-date
Current Price: $21.43
Market Capitalization: $1111.11 billion
52-week Price Range: $1.37 - $15.75
Members Only! Login / Register to view

7) Imunon, Inc. (IMNN)

Price Gain: 116.18% 2024 year-to-date
Current Price: $1.47
Market Capitalization: $14.95 million
52-week Price Range: $0.48 - $2
No ETFs - No Recent Candlestick Patterns

8) ZVZZT Pharma Corp Ltd. (ZVZZT)

Price Gain: 112.29% 2024 year-to-date
Current Price: $21.43
Market Capitalization: $1111.11 billion
52-week Price Range: $0.41 - $3.26
Members Only! Login / Register to view

9) Dyne Therapeutics, Inc. (DYN)

Price Gain: 91.28% 2024 year-to-date
Current Price: $25.44
Market Capitalization: $2.23 billion
52-week Price Range: $6.4 - $30.27
No ETFs - No Recent Candlestick Patterns

10) ZVZZT Pharma Corp Ltd. (ZVZZT)

Price Gain: 89.95% 2024 year-to-date
Current Price: $21.43
Market Capitalization: $1111.11 billion
52-week Price Range: $0.79 - $4.38
Members Only! Login / Register to view

There's more... See price performance, YTD-gains, market-cap and other details of all the 144 Pharma stocks with sorting features in a tabular format. Alternatively, one can also explore the List of Top Pharma ETFs.

Best Performing Stock Screener:

Top Performing Pharma StocksAll Pharma StocksAll Pharma ETFsTop Dividend-paying Pharma StocksTop Pharma Stocks for Apr 2024

Performance of Top Pharma Stocks

Here's a look at the basic details and how the above mentioned stocks fared during the period:

1) Shineco, Inc.

Shineco, Inc., together with its subsidiaries, produces, distributes, and sells health and well-being focused plant-based products in China. It processes ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of Shineco, Inc..
The -based sector company Shineco, Inc. (SISI) holds the number two spot among the best performing stocks of the Pharma sector. Classified as the business, the stock price of Shineco, Inc. ended the previous year at a price of $0.11 per share while it reached the level of $0.66 apiece as of Apr 15, 2024 translating to a percentage change in stock price of 486.15%. As of writing, the company's market-cap value stands at $4.23 million.

2) ZVZZT Pharma Corp Ltd. (ZVZZT)

This part of the best performing stocks list of Pharma category is for Members Only!
Please Login / Register to view the entire list, and enjoy unlimited access.
Registered members also get ad-free, unrestricted access to other sections of the site.

3) Nektar Therapeutics

Nektar Therapeutics, incorporated on June 3, 1998, is a biopharmaceutical company that discovers and develops medicines in areas of high unmet medical need. The Companys research and development pipeline of ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of Nektar Therapeutics.
The -based Nektar Therapeutics (NKTR) belongs to the sector and is categorized as a company. The stock of Nektar Therapeutics ended the previous year at a price of $0.57 per share. As of Apr 15, 2024, the stock price has reached $1.57 apiece, which indicates a change of 177.88 percent making the company rank among the top performing stocks of the Pharma for the year 2024 till date. At the end of the last year, company's market capitalization stood at $107.79 million. It has now changed to $306.64 million as of writing.

4) ZVZZT Pharma Corp Ltd. (ZVZZT)

5) Clever Leaves Holdings Inc.

Clever Leaves Holdings Inc. cultivates, extracts, manufactures, and commercializes pharmaceutical-grade cannabinoid products in Colombia, Portugal, ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of Clever Leaves Holdings Inc..
At number six in the list of top stocks stands Clever Leaves Holdings Inc. (CLVRW), which saw a change in its stock price from the level of $0.02 apiece during previous year December end to the price of $0.04 per share as of Apr 15, 2024. It translates to a change of 135.8 percentage. The -headquartered sector company also saw its market value change from $0 million to $0 million.

6) ZVZZT Pharma Corp Ltd. (ZVZZT)

7) Imunon

Imunon, Inc., a clinical stage biotechnology company, engages in the development of immunotherapies and vaccines to treat cancer and infectious diseases. ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of Imunon .
Based on the market-cap change from $6.39 million to $14.95 million during the given months of the year 2024 and the share price change from $0.68 per share to a price of $1.47 per share as of Apr 15, 2024, Imunon, Inc. (IMNN) was successful in generating YTD returns of 116.18 percentage. Standing at the number eight rank in the top performing list of Pharma stocks, the -based Imunon is categorized as the sub-sector business which falls under the larger sector.

8) ZVZZT Pharma Corp Ltd. (ZVZZT)

9) Dynegy Inc.

Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of Dynegy Inc..
The number ten spot in the list of top performing stocks of the Pharma sector is taken by Dyne Therapeutics, Inc. (DYN). The company's stock price changed from $13.3 per share at the end of December of the previous year to the price of $25.44 per share as of writing. Overall, the stock managed to realized price change of 91.28 percent during the given time period. The corresponding change in the market capitalization value of the -based sector company was from $816.3 million to $2.23 billion. Being ranked in the top 10 best performing stocks of the Pharma sector, the company also succeeded in outperforming the returns generated by some of the popular stock market indexes.